Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Jiangsu Qianren Biotechnology

Request full access

Pharmaceuticals for chronic and oncological diseases

ChinaFounded 2016Biotech & Life Sciences

About Jiangsu Qianren Biotechnology

Jiangsu Qianren Biotechnology Co., Ltd. is a holding company established in 2016 and based in Jiangsu, China. The company focuses on the research and development of biological products and Class I medical devices.

The firm is actively engaged in the pharmaceutical sector, conducting numerous clinical trials to establish the bioequivalence of its drug products against existing market leaders. Notable trials include studies on Teneligliptin Hydrobromide tablets for diabetes, Riociguat tablets for pulmonary hypertension in comparison to Bayer AG's product, and Sitagliptin with Metformin extended-release tablets. These trials are a core part of its business model, which centers on developing and bringing generic or improved versions of established drugs to the market. The company's operations involve randomized, open-label, single-dose, and crossover studies under both fasting and fed conditions to meet regulatory standards for bioequivalence.

As of early 2016, the company's business scope was defined to include biological products and R&D, and it holds a number of patents in its field.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
19.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Diabetes, Biotechnology, Drug Development, Chronic Disease, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2025 — — Undisclosed ↗
SERIES A✓Equity / VC Jan 2024 $14M $55M Prosperity Investment · Shanghai Cooperation Organization (Lianyungang) International Logistics Park Development Fund ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Jiangsu Qianren Biotechnology in its local ecosystem

Live from Dealroom

The Jiangsu Qianren Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Prosperity Investment
  • Shanghai Cooperation Organization (Lianyungang) International Logistics Park Development Fund
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Jiangsu Qianren Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Jiangsu Qianren Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.